Skip to navigation Skip to content

Participate in a Clinical Trial

Without the participation of people with MS, it would be impossible to develop new and better therapies and other interventions.

Clinical Trials in MS


The latest clinical research in MS, including trials funded by the Society and trials in progressive MS.

Read more

Read more

Posting a Trial

If you would like us to post a study on these pages, please email studies@nmss.org to find out what information you need to submit for review.

Share




Clinical trials help to determine if treatments are safe and effective. Studies are monitored to ensure that the rights and safety of all participants are protected. Make an informed decision before agreeing to participate. Read more in our Guide to Participating in Clinical Trials.

Clinical Trials In Your Area

Interested in clinical trials? Simply search by state, type of MS or keyword and see what’s going on in your area.

  1. Clinical Trial: Multiple Sclerosis Online Course

    The MS Online Course study is being conducted by the University of Melbourne to investigate how lifestyle recommendations delivered through an online learning platform affect Multiple Sclerosis.Participants will join a 6-week online program to learn more about how of diet, ex...
  2. Clinical Trial: Probiotic for Urinary Symptoms Among People Who Use Catheters (Remote)

    To qualify for this study you must be 18 years or older, use an indwelling catheter OR Intermittent catheter, be diagnosed with MS, and have a history of 2 or more episodes of urinary symptoms or infection in the past year. Researchers at MedStar National Rehabilitation Hos...
  3. Clinical Trial: Ocrelizumab vs. fingolimod in children and adolescents with MS

    Study is seeking to assess the safety and effectiveness of ocrelizumab (administered by intravenous infusion every 24 weeks) in comparison to fingolimod (one oral capsule taken once per day) in children and adolescents ages 10 to 18 with relapsing-remitting MS. The study is co...
  4. Clinical Trial: Nabiximols Oromucosal Spray for Spasticity Due to MS

    Particpiants will remain on their current medications for spacticity.  They will keep a diary of their daily spasm count.  They will then either take Nabiximol or Placebo for a period of 12 weeks and monitor their symptoms.  THe trial will be anout 18 weeks including a one mon...
  5. Clinical Trial: A phase 1 safety study of ANK-700 in people with relapsing-remitting MS

    Study Rationale: Multiple sclerosis (MS) is a neurological disease that causes damage to the brain and spinal cord, and steadily worsens over time. As the central nervous system (CNS) controls most body functions, people living with MS can experience a wide range of symptoms. ...
  6. Clinical Trial: Plant-Derived Oral Cannabinoid Spray to Treat Muscle Spasticity

    SUMMARY: Investigators are recruiting 446 people with MS worldwide who are being treated for spasticity for a study testing whether adding nabiximols (an oral spray), to ongoing antispasticity therapy can reduce MS-related muscle spasms. The study is sponsored by Jazz Pharmace...
  7.  |<  <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 >  >|

Share


© 2022 The National Multiple Sclerosis Society is a tax exempt 501(c)3 nonprofit organization. Its Identification Number (EIN) is 13-5661935.